Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-08
DOI
10.1038/s41598-021-02864-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
- (2021) Takeo Ishii et al. FEBS Open Bio
- Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
- (2020) Etienne Empweb Anger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Boris Bikbov et al. LANCET
- Targeting the progression of chronic kidney disease
- (2020) Marta Ruiz-Ortega et al. Nature Reviews Nephrology
- Effects of ATRAP in Renal Proximal Tubules on Angiotensin‐Dependent Hypertension
- (2019) Sho Kinguchi et al. Journal of the American Heart Association
- CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress
- (2019) Seung Joo Lee et al. PLoS One
- Mechanisms of Renal Fibrosis
- (2018) Benjamin D. Humphreys Annual Review of Physiology
- Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets
- (2018) Wenshan Lv et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Renal tubule injury: a driving force toward chronic kidney disease
- (2018) Bi-Cheng Liu et al. KIDNEY INTERNATIONAL
- Renal fibrosis: Primacy of the proximal tubule
- (2018) Leslie S. Gewin MATRIX BIOLOGY
- Aristolochic acid I determine the phenotype and activation of macrophages in acute and chronic kidney disease
- (2018) Mohsen Honarpisheh et al. Scientific Reports
- An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model
- (2017) Ryu Kobayashi et al. KIDNEY INTERNATIONAL
- Adipocyte‐Specific Enhancement of Angiotensin II Type 1 Receptor‐Associated Protein Ameliorates Diet‐Induced Visceral Obesity and Insulin Resistance
- (2017) Kengo Azushima et al. Journal of the American Heart Association
- Anti-TNF-α Inhibitors: A New Therapeutic Approach for Inflammatory Immune-Mediated Diseases: An Update upon Efficacy and Adverse Events
- (2017) G. Murdaca et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury
- (2015) Alaa S. Awad et al. KIDNEY INTERNATIONAL
- TNF receptors: signaling pathways and contribution to renal dysfunction
- (2015) Rafia S. Al-Lamki et al. KIDNEY INTERNATIONAL
- Macrophages in Kidney Injury, Inflammation, and Fibrosis
- (2015) Qi Cao et al. PHYSIOLOGY
- Deletion of the angiotensin II type 1 receptor–associated protein enhances renal sodium reabsorption and exacerbates angiotensin II–mediated hypertension
- (2014) Masato Ohsawa et al. KIDNEY INTERNATIONAL
- Inflammatory processes in renal fibrosis
- (2014) Xiao-Ming Meng et al. Nature Reviews Nephrology
- TNF and MAP kinase signalling pathways
- (2014) Guadalupe Sabio et al. SEMINARS IN IMMUNOLOGY
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
- (2013) Ron T Gansevoort et al. LANCET
- Angiotensin Receptor–Binding Protein ATRAP/ Agtrap Inhibits Metabolic Dysfunction With Visceral Obesity
- (2013) Akinobu Maeda et al. Journal of the American Heart Association
- Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
- (2012) J. Gupta et al. Clinical Journal of the American Society of Nephrology
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
- (2010) Young Sun Kang et al. KIDNEY INTERNATIONAL
- Decrease in Tumor Necrosis Factor-α Receptor-Associated Death Domain Results from Ubiquitin-Dependent Degradation in Obstructive Renal Injury in Rats
- (2009) Taro Misaki et al. AMERICAN JOURNAL OF PATHOLOGY
- Effects of Liposome Clodronate on Renal Leukocyte Populations and Renal Fibrosis in Murine Obstructive Nephropathy
- (2009) Koichiro Kitamoto et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Pretreatment With the Tumor Nerosis Factor-α Blocker Etanercept Attenuated Ischemia-Reperfusion Renal Injury
- (2009) D.E. Choi et al. TRANSPLANTATION PROCEEDINGS
- Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice
- (2008) A. K. H. Lim et al. DIABETOLOGIA
- TNF-α deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction
- (2008) Yoshifumi Morimoto et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Aristolochic acid nephropathy: A worldwide problem
- (2008) Frédéric D. Debelle et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now